NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has acquired the oligonucleotide manufacturing division of DNA Technology for an undisclosed amount.
The buy of the DNA Technology division, based in Aarhus, Denmark, provides Biosearch with a "highly skilled production team with a mature quality system and an established European customer base focused in the Nordic countries," Biosearch said in a statement. The company, which was founded in 1992, provides custom-manufactured oligonucleotides in the Nordic region, with a focus on highly modified synthetic DNA and RNA for the life science research and healthcare markets.
DNA Technology also is ISO 9001:2008-certified. Biosearch said that it will provide state of the art manufacturing tools and access to its IP portfolio to DNA Technology. As a result, the Danish firm will be able to expand its production capabilities and product offerings. The transaction was completed in December 2012.
Biosearch also said that it acquired German controlled-pore glass (CPG) firm VitraBio. That transaction was completed more than a year ago in September 2011, but BioSearch hadn't previously disclosed the deal. The Novato, Calif.-based company said that it plans to add chemical manufacturing capabilities to VitraBio's Steinach facility in Germany "to supplement existing US production of specialty amidites and modified CPGs."
VitraBio was founded in 2003 and is ISO 9001:2008-certified. Terms of the acquisition were not disclosed.
Biosearch supplies nucleic acid-based products for genomics research.